SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:lup.lub.lu.se:dacf31dd-363a-476a-930e-26df9a7de02d"
 

Search: id:"swepub:oai:lup.lub.lu.se:dacf31dd-363a-476a-930e-26df9a7de02d" > Switching from bran...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Lavorini, Federico (author)

Switching from branded to generic inhaled medications: potential impact on asthma and COPD

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2013-11-14
  • Informa Healthcare,2013

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:dacf31dd-363a-476a-930e-26df9a7de02d
  • https://lup.lub.lu.se/record/4273354URI
  • https://doi.org/10.1517/17425247.2013.852182DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:vet swepub-contenttype

Notes

  • Pressure on healthcare budgets is increasing, while at the same time patent protection for many branded inhaled medications has expired, leading to the development and growing availability of generic inhaled medicines. Generic inhaled drugs are therapeutically equivalent to original branded options but may differ in their formulation and inhalation device. This new situation raises questions about the potential impact of switching from branded to generic drug/inhaler combination products in patients with asthma or COPD, with or without their consent, in countries where this is permitted. Inhalation devices, particularly dry powder inhalers, vary markedly in their design, method of operation and drug delivery to the lungs. Current guidelines stress the importance of training patients how to use their inhalers but offer little or no guidance on how this should be achieved. Non-adherence to therapy and incorrect inhaler usage are recognised as major factors in poorly or uncontrolled asthma and COPD and switching patients to a different inhaler device may exacerbate these problems, particularly in patients who disagree to switch. Where switching is permitted or mandatory, adequate patient instruction and follow-up monitoring should be provided routinely.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Ninane, Vincent (author)
  • Haughney, John (author)
  • Bjermer, LeifLund University,Lunds universitet,Lungmedicin, allergologi och palliativ medicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Respiratory Medicine, Allergology, and Palliative Medicine,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)lung-lbj (author)
  • Molimard, Mathieu (author)
  • Dekhuijzen, Richard P. N. (author)
  • Lungmedicin, allergologi och palliativ medicinSektion II (creator_code:org_t)

Related titles

  • In:Expert Opinion on Drug Delivery: Informa Healthcare10:12, s. 1597-16021742-52471744-7593

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view